...
首页> 外文期刊>Frontiers in Neurology >Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis
【24h】

Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis

机译:动脉内溶栓治疗急性中央视网膜动脉阻塞:系统评价和荟萃分析

获取原文

摘要

Background and purpose Acute central retinal artery occlusion (CRAO) is a serious ophthalmologic emergency that may result in monocular blindness. To date, studies evaluating intra-arterial thrombolysis (IAT) have not shown a definitive clinical benefit. We have conducted a systematic review with a meta-analysis to effectively evaluate this treatment option. Methods A systematic literature search was focused on studies containing five or more patients undergoing IAT that included a control group treated with standard therapy. Pooled meta-analysis was performed. Results Five retrospective controlled studies and one randomized clinical trial were identified satisfying all inclusion criteria resulting in the analysis of 236 patients treated with IAT and 255 patients treated with ST. A pooled fixed effects analysis resulted in an estimated odds ratio of 2.52, 95% CI (1.69, 3.77) ( P ?
机译:背景与目的急性视网膜中央动脉阻塞(CRAO)是一种严重的眼科急症,可能导致单眼失明。迄今为止,评估动脉内溶栓(IAT)的研究尚未显示出明确的临床益处。我们已经进行了荟萃分析,系统地审查了有效评估这种治疗方案。方法:系统性文献检索的重点是包含五个或更多接受IAT治疗的患者的研究,其中包括接受标准疗法治疗的对照组。进行汇总荟萃分析。结果确定了5项符合所有入选标准的回顾性对照研究和一项随机临床试验,从而对236例接受IAT治疗的患者和255例接受ST治疗的患者进行了分析。汇总的固定效应分析得出了有利于IAT的估计比值比为2.52、95%CI(1.69,3.77)(P 0.0001)。结论IAT是CRAO的有前途的治疗选择,潜力巨大。需要进一步的随机试验以建立明显的获益并确保干预的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号